furexel ivermectine 18.7 mg/g or. paste pre-filled syr.
boehringer ingelheim animal health belgium sa-nv - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse
ivermax 18,7 mg/g or. paste pre-filled syr.
eco animal health europe ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse
bimectin 18,7 mg/g or. paste pre-filled syr.
bimeda animal health ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse
nexmectin 18,7 mg/g or. paste pre-filled syr.
eco animal health europe ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse
noromectin 1,87 % oral paste for horses 18,7 mg/g or. paste pre-filled syr.
norbrook laboratories (ireland) ltd. - ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - ivermectin 18.7 mg/g - ivermectin - horse
noromectin praziquantel duo 18,7 mg/g - 140,3 mg/g or. paste pre-filled syr.
norbrook laboratories (ireland) ltd. - praziquantel 140,3 mg/g; ivermectin 18,7 mg/g - oral paste - 18,7 mg/g - 140,3 mg/g - ivermectin 18.7 mg/g; praziquantel 140.3 mg/g - ivermectin, combinations - horse
tramadol hydrochloride tablet, coated
quality care products, llc - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride tablets, usp are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)] , reserve tramadol hydrochloride tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: - have not been tolerated or are not expected to be tolerated. - have not provided adequate analgesia or are not expected to provide adequate analgesia. tramadol hydrochloride tablets, usp are contraindicated for: - all children younger than 12 years of age [ see warnings and precautions (5.4) ]. - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy
18 fluodeoxiglucosa en solucion tamponada (solución inyectable)
radiofarmacia de centroamerica s.a - fluodeoxiglucosa 18 f - fluodeoxiglucosa 18 f....15 mci/0.55 gbq a 3ci/111 gbq en 3 ml a 19 ml
roferon-a
roche products (nz) ltd - interferon alfa-2a 18 miu - powder for injection - 18 miu - active: interferon alfa-2a 18 miu excipient: albumin sodium chloride water for injection
stalevo
orion pharma (nz) limited - carbidopa monohydrate 20.25mg equivalent to 18.75 mg carbidopa; ; entacapone 200mg; levodopa 75mg - film coated tablet - 75mg/18.75mg/200mg - active: carbidopa monohydrate 20.25mg equivalent to 18.75 mg carbidopa entacapone 200mg levodopa 75mg excipient: croscarmellose sodium ethanol glycerol hypromellose iron oxide red magnesium stearate maize starch mannitol polysorbate 80 povidone purified water sucrose titanium dioxide - stalevo is indicated for the treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.